Arbutus Biopharma (ABUS) FCF Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
84,640.00 |
| Dec 31, 2025 |
19,029.00 |
| Sep 30, 2025 |
-29,956.00 |
| Jun 30, 2025 |
43,901.00 |
| Mar 31, 2025 |
27,729.00 |
| Dec 31, 2024 |
16,825.00 |
| Sep 30, 2024 |
-77,354.00 |
| Jun 30, 2024 |
189,239.00 |
| Mar 31, 2024 |
118,073.00 |
| Dec 31, 2023 |
22,495.00 |
| Sep 30, 2023 |
37,859.00 |
| Jun 30, 2023 |
101,172.00 |
| Mar 31, 2023 |
99,771.00 |
| Dec 31, 2022 |
14,135.00 |
| Sep 30, 2022 |
-8,806.00 |
| Jun 30, 2022 |
35,168.00 |
| Mar 31, 2022 |
823,223.00 |
| Dec 31, 2021 |
739,332.00 |
| Sep 30, 2021 |
144,176.00 |
| Jun 30, 2021 |
480,955.00 |
